ISORAY SHAREHOLDER ALERT: Faruqi & Faruqi, LLP the Investigation of IsoRay, Inc. and its Officers for Potential Securities Stock Fraud in Connection with the Doctoring of Study Results - ISR
NEW YORK, May 23, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at IsoRay, Inc. ("IsoRay" or the "Company") (NYSE MKT: ISR).
The investigation focuses on whether IsoRay and its executives violated federal securities laws by manipulating the Company's lung cancer study results in order to prop up the IsoRay stock price.
On May 22, 2015, the market news website TheStreet.com published an article titled "IsoRay Takes Liberties With Lung Cancer Study Results to Prop Up Stock Price," which reported that "To make up for the inability to deliver revenue growth -- and prop up its stock price -- IsoRay issues a lot of promotional press releases, some of which take liberties with clinical data using clever, selective editing." The article goes on to give the following example: IsoRay recently trumpeted a 100% survival at five years in high risk patients being treated with Cesium-131 without mentioning that the comparable five year survival rate for patients undergoing surgery alone is 98%.
Request more information now by clicking here: www.faruqilaw.com/ISR. There is no cost or obligation to you.
Take Action
If you invested in IsoRay stock or options and would like to discuss your legal rights, please visit www.faruqilaw.com/ISR. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding IsoRay's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Contact:
FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone: (877) 247-4292 or (212) 983-9330
Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO
SOURCE Faruqi & Faruqi, LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article